<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">3086</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2020.122210</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Significance of Neutrophil Lymphocyte Ratio and High Sensitivity C-Reactive Protein in Type 2 Diabetic Patients&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>A.</surname><given-names>Velayutharaj</given-names></name></contrib><contrib contrib-type="author"><name><surname>R.</surname><given-names>Saraswathi</given-names></name></contrib><contrib contrib-type="author"><name><surname>L.</surname><given-names>Muthumani</given-names></name></contrib><contrib contrib-type="author"><name><surname>R.</surname><given-names>Shivakumar</given-names></name></contrib><contrib contrib-type="author"><name><surname>M.</surname><given-names>Sivakumar</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>24</day><month>11</month><year>2020</year></pub-date><volume>2)</volume><issue/><fpage>66</fpage><lpage>69</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Introduction: Low-grade inflammation is the basic pathophysiology in metabolic syndrome and the development of T2DM. Previous studies have demonstrated that increased neutrophil-lymphocyte ratio (NLR) is a marker of cardiovascular disease and cancer. Apart from many inflammatory markers, NLR is believed to be the balance between innate (neutrophils) and adaptive (lymphocytes) immune system responses to the low-grade inflammation. Methods: The present study was to find the relationship between NLR and hsCRP (High sensitive C reactive protein) in patients with T2DM in a tertiary care centre. Age and sex-matched 60 T2DM patients (males 32, female 28) were included in this study. After getting the written informed consent 5ml of fasting blood sample was collected for the analysis of fasting blood glucose, Total, differential WBC count and High sensitive Creative protein. Results: Our study showed that there is a strong positive correlation between increased NLR and hsCRP.357 (p__ampersandsignle; 0.005). Here, it is important to note that, males have low levels of hsCRP (2.63__ampersandsignplusmn;3.23) than females (4.82__ampersandsignplusmn;4.16) and these changes are also statistically significant (p__ampersandsignle; 0.026). Conclusion: The White blood cell count is one of the markers of subclinical inflammation. In diabetes, due to the presence of low-grade inflammation, the white cell count, NLR and hsCRP were increased. Hence, by assessing NLR, which is a simple clinical investigation will be useful in T2DM patients to control future vascular risk events.&#13;
</p></abstract><kwd-group><kwd> White blood cell (WBC) count</kwd><kwd> Neutrophil lymphocyte ratio (NLR)</kwd><kwd> Type 2 diabetes mellitus (T2DM)</kwd><kwd> High sensitive C-reactive protein (hsCRP)</kwd></kwd-group></article-meta></front></article>
